{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:09:49Z","timestamp":1793916589061,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jcrc.2025.155330","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T23:08:00Z","timestamp":1763334480000},"page":"155330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effects on mortality of blood purification techniques in severe septic shock patients. An updated Bayesian network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"92","author":[{"given":"Massimo","family":"Meco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Agosteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Zulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Nisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Giustiniano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2025.155330_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2025.155330_bb0010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","article-title":"(2019) frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis","volume":"23","author":"Vincent","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2025.155330_bb0015","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2025.155330_bb0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jcrc.2025.155330_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/cc9411","article-title":"Clinical review: blood purification for sepsis","volume":"5","author":"Rimmele","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2025.155330_bb0030","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/ALN.0000000000002820","article-title":"(2019) blood purification and mortality in sepsis and septic shock: a systematic review and meta-analysis of randomized trials","volume":"131","author":"Putzu","year":"2019","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jcrc.2025.155330_bb0035","series-title":"Cochrane Handbook for Systematic Reviews of InterventionsVersion 5.1.0 [updated March 2011]","year":"2025"},{"key":"10.1016\/j.jcrc.2025.155330_bb0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.jcrc.2025.155330_bb0045","series-title":"Technical support document 4. Inconsistency in networks of evidence based on randomized controlled trials","author":"Dias","year":"2014"},{"key":"10.1016\/j.jcrc.2025.155330_bb0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12874-019-0829-2","article-title":"BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network meta-analyses","volume":"19","author":"Beliveau","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jcrc.2025.155330_bb0055","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s00134-008-1127-3","article-title":"A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock","volume":"34","author":"Boussekey","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2025.155330_bb0060","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00134-002-1410-7","article-title":"Plasmapheresis in severe and septic shock: a prospective, randomized, controlled trial","volume":"28","author":"Busund","year":"2002","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.jcrc.2025.155330_bb0065","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019058","article-title":"Clinical effects of hemoadsorption combined with pulse high-volume hemofiltration on septic shock","volume":"99","author":"Chu","year":"2020","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155330_bb0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/SHK.0000000000000725","article-title":"Modulation by polymyxin-b hemoadsorption of inflammatory response related to severe peritonitis","volume":"47","author":"Coudroy","year":"2017","journal-title":"Shock"},{"issue":"23","key":"10.1016\/j.jcrc.2025.155330_bb0075","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoadsorption in abdominal septic shock. The EUPHAS randomized controlled trial","volume":"301","author":"Cruz","year":"2009","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.jcrc.2025.155330_bb0080","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","article-title":"Effect of targeted polymyxin B hemoadsorption on 28-day mortality in patients with septic shock and elevated endotoxin level. The EUPHRATES randomized clinical trial","volume":"320","author":"Dellinger","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jcrc.2025.155330_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030139","article-title":"The premature closure of ROMPA clinical trial: mortality reduction in septic shock by plasma adsorption","volume":"9","author":"Gimenez-Esparza","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcrc.2025.155330_bb0090","series-title":"Coupled plasma filtration adsorption (CPFA) is a technique in which plasma, separated from whole blood by a plasma filter, passes through a resin adsorption cartridge; this is not necessarily followed by hemofiltration","year":"2025"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155330_bb0095","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1744-9987.2010.00825.x","article-title":"Removal of humoral mediators and the effect on the survival of septic patients by hemoadsorption with neutral microporous resin column","volume":"14","author":"Huang","year":"2010","journal-title":"Therap Apher Dialysis"},{"key":"10.1016\/j.jcrc.2025.155330_bb0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcrc.2018.11.003","article-title":"Extracorporeal cytokine adsorption in septic shock: a proof of concept randomized, controlled pilot study","volume":"49","author":"Hawchar","year":"2019","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2025.155330_bb0105","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00134-013-2967-z","article-title":"High volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicenter randomized controlled trial","volume":"39","author":"Joannes-Boyau","year":"2013","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155330_bb0110","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/ndt\/16.2.320","article-title":"Effects of continuous haemofiltration vs intermittent haemodialysis on sydstemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trila","volume":"16","author":"John","year":"2001","journal-title":"Nephrol Dial Tranplant"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155330_bb0115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/SHK.0000000000001503","article-title":"Endotoxin removal in septic shock with the ALTECO LPS adsorber was safe but showed no benefit compared to placebo in the double-blind randomized controlled trial-the asset study","volume":"54","author":"Lipcsey","year":"2020","journal-title":"Shock"},{"key":"10.1016\/j.jcrc.2025.155330_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003536","article-title":"Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomized controlled clinical trial","volume":"4","author":"Livigni","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcrc.2025.155330_bb0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s000110050442","article-title":"Koide H treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor 4 and \u03b2-thromboglobulin","volume":"48","author":"Nakamura","year":"1999","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jcrc.2025.155330_bb0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/tcic.12.5-6.223.228","article-title":"Effect of polymyxin B-immobilized fiber on various mediators in patients with hypothermic sepsis","volume":"12","author":"Nakamura","year":"2025","journal-title":"Clin Intensive Care"},{"key":"10.1016\/j.jcrc.2025.155330_bb0135","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s00134-004-2357-7","article-title":"Effect of polymyxin B-immobilized fiber resorption in patients with sepsis","volume":"30","author":"Nakamura","year":"2004","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155330_bb0140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/j.ajkd.2016.02.049","article-title":"High-dose versus conventional-dose continuous venovenous hemodiafiltration and kidney survival and cytokine removal in sepsis-associated acute kidney injury: a randomized controlled trial","volume":"68","author":"Park","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcrc.2025.155330_bb0145","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/CCM.0b013e3181962316","article-title":"Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial","volume":"37","author":"Payen","year":"2009","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155330_bb0150","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","article-title":"Early use of polymyxin B hemoadsorption in patietns with septic shock due to peritonitis: a multicenter randomized control trial","volume":"41","author":"Payen","year":"2015","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.jcrc.2025.155330_bb0155","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00134-015-4056-y","article-title":"Very high volume hemofiltration with the cascade system in septic shock patients","volume":"41","author":"Quenot","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2025.155330_bb0160","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/00003246-199910000-00003","article-title":"(1999) Continous plasmafiltration in sepsis syndrome","volume":"27","author":"Reeves","year":"1999","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155330_bb0165","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/SHK.0000000000002121","article-title":"Hemoperfusion using LPS-selective mesoporous polymeric adsorbent in septic shock a multicenter randomized clinical trial","volume":"59","author":"Rey","year":"2013","journal-title":"Shock"},{"issue":"8","key":"10.1016\/j.jcrc.2025.155330_bb0170","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/01.CCM.0000132902.54925.B5","article-title":"Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected gram-negative sepsis","volume":"32","author":"Reinhart","year":"2004","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.jcrc.2025.155330_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187015","article-title":"The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial","volume":"12","author":"Schadler","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jcrc.2025.155330_bb0180","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13054-022-04003-2","article-title":"Clnical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial","volume":"26","author":"Stahl","year":"2022","journal-title":"Crit Care"},{"issue":"12","key":"10.1016\/j.jcrc.2025.155330_bb0185","first-page":"783","article-title":"Alteco endotoxin hemoadsorption in gram-negative septic shock patients","volume":"18","author":"Shum","year":"2018","journal-title":"Ind J Crit Care Med"},{"key":"10.1016\/j.jcrc.2025.155330_bb0190","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13054-018-2077-y","article-title":"The effect of polymyxin B hemoadsorption on modulation of human leukocyte antigen DR in severe sepsis patients","volume":"22","author":"Srisawat","year":"2018","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155330_bb0195","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1526-0968.2002.00416.x","article-title":"Continuous hemodiafiltration with polymyxin B immobilizer fiber is effective in patients with sepsis syndrome and acute renal failure","volume":"6","author":"Suzuki","year":"2002","journal-title":"Ther Apher"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155330_bb0200","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ndt\/gfr486","article-title":"Effect of intensity of continuous renal replacement in patients with sepsis and acute renal injury: single-center randomized clinical trial","volume":"27","author":"Zhang","year":"2012","journal-title":"Nephrol Dial Tranplant"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155330_bb0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13613-023-01224-8","article-title":"Effects of enhanced adsorption haemofiltration versus haemoadsorption in severe, refractory septic shock with high leves of endotoxemia: the ENDoX bicentric, randomized, controlled trial","volume":"13","author":"Wendel-Garcia","year":"2023","journal-title":"Ann Intensice Care"},{"key":"10.1016\/j.jcrc.2025.155330_bb0210","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155330_bb0215","first-page":"426","article-title":"Sepsis-induced immunoparalysis: mechanisms, markers, and treatment options","volume":"81","author":"Hamers","year":"2015","journal-title":"Minerva Anesthesiol"},{"issue":"9","key":"10.1016\/j.jcrc.2025.155330_bb0220","first-page":"840","article-title":"Interpreting the mechanisms of continuous renal replacement therapy in sepsis and septic shock","volume":"369","author":"Ronco","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2025.155330_bb0225","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3109\/0886022X.2013.815089","article-title":"Techniques of extracorporeal cytokine removal: a systematic review of human studies","volume":"35","author":"Atan","year":"2013","journal-title":"Ren Fail"},{"key":"10.1016\/j.jcrc.2025.155330_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40560-016-0163-2","article-title":"Renal replacement therapy neutralizes elevated MIF levels in septic shock","volume":"4","author":"Pohl","year":"2016","journal-title":"J Intensive Care"},{"key":"10.1016\/j.jcrc.2025.155330_bb0235","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s001340100963","article-title":"High-volume haemofiltration in human septic shock","volume":"27","author":"Cole","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2025.155330_bb0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000067860","article-title":"Sorbents in acute renal failure and the systemic inflammatory response syndrome","volume":"21","author":"Winchester","year":"2003","journal-title":"Blood Purif"},{"key":"10.1016\/j.jcrc.2025.155330_bb0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000468911","article-title":"Ronco C extracorporeal sorbent technologies: basic concepts and clinical application","volume":"190","author":"Clark","year":"2017","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jcrc.2025.155330_bb0250","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1526-0968.2003.00005.x","article-title":"Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin)","volume":"7","author":"Shoji","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jcrc.2025.155330_bb0255","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000493523","article-title":"A new series of sorbent devices for multiple clinical purposes: current evidence and future directions","volume":"47","author":"Ankawi","year":"2019","journal-title":"Blood Purif"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155330_bb0260","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000528150","article-title":"The clinical and laboratory efficacy of ha 330 treatment combined with continuous renal replacement therapy in septic shock patients: a case series","volume":"52","author":"Onuk","year":"2023","journal-title":"Blood Purif"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155330_bb0265","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000505565","article-title":"Efficacy of HA 330 hemoadsorption adsorbent in patients followed in the intensive care unit for septic shock and acute kidney injry and treated with CVVHDF","volume":"49","author":"Ka\u00e7ar","year":"2020","journal-title":"Blood Purif"},{"issue":"9","key":"10.1016\/j.jcrc.2025.155330_bb0270","article-title":"Case series: Efficacy and safety of hemoadsorption with HA 330 adsorber in septic pediatric patients with cancer","volume":"11","author":"Sazonov","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jcrc.2025.155330_bb0310","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MAJ.0000000000000341","article-title":"(2015) cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment","volume":"349","author":"Omar","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jcrc.2025.155330_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266820","article-title":"Intraoperative hemoadsorption in high-risk patients with infective endocarditis","volume":"17","author":"Haidari","year":"2022","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.jcrc.2025.155330_bb0320","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.arthro.2021.04.070","article-title":"Understanding network meta-analysis conclusions requires scrutinity of methods and results: introduction to NMA and the geometry of evidence","volume":"37","author":"Cote","year":"2021","journal-title":"Artroscopy"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412500317X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412500317X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:41:23Z","timestamp":1768851683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088394412500317X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":57,"alternative-id":["S088394412500317X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155330","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects on mortality of blood purification techniques in severe septic shock patients. An updated Bayesian network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155330"}}